{"id":176704,"date":"2026-07-29T15:00:57","date_gmt":"2026-07-29T09:30:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=176704"},"modified":"2026-07-29T15:00:57","modified_gmt":"2026-07-29T09:30:57","slug":"concord-biotech-ltd-share-price-rise-today","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/concord-biotech-ltd-share-price-rise-today\/","title":{"rendered":"Concord Biotech Ltd. (CONCORDBIO): Concord Biotech Share Price Rises 5.88% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Concord Biotech Share Price rises 5.88% to Rs 1,328, marking a significant gain in the mid cap category.<\/p>\n<p style=\"margin-top:0!important;\">Concord Biotech Share Price has seen a notable increase today, rising by 5.88% to reach Rs 1,328. This significant movement places the company in the spotlight within the mid cap category, where it has a market capitalisation of Rs 13,150.26 crore. The stock opened at Rs 1,265.1 and reached a high of Rs 1,330, demonstrating strong investor interest. The day&#8217;s trading volume was substantial, with 140,732 shares changing hands, indicating heightened market activity.<\/p>\n<p><  The company's performance today has attracted attention, although the specific catalyst behind this movement is not identified in the available data. Investors and analysts are keenly observing the stock's performance, given its significant gain in a single trading session.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Ltd_CONCORDBIO_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Concord Biotech Ltd. (CONCORDBIO) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,328<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,254.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 73.8 (+5.88%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,265.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,330<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,262.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8,934<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8,934<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,31,798<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,40,732<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.19 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,150.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) traded at Rs 1,328. versus the previous close of Rs 1,254.2, a rise of 5.88%. The stock opened at Rs 1,265.1, reached Rs 1,330, touched Rs 1,262.9. Reported volume was 8,934.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Ltd_CONCORDBIO_Fundamental_Analysis\"><\/span><strong>Concord Biotech Ltd. (CONCORDBIO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,150.26 crore<\/td>\n<\/tr>\n<\/table>\n<p>The healthcare sector benchmark, with a P\/E median of 26.44 and an average of 87.62, provides a context for evaluating Concord Biotech&#8217;s valuation. The sector&#8217;s P\/B median is 1.9, with an average of 2.55, indicating a range of valuations within the industry. Concord Biotech&#8217;s performance in terms of ROE and ROCE, compared to sector averages of 15.18% and 17.64% respectively, will be key indicators of its financial health and operational efficiency.<\/p>\n<p>Investors will be keen to assess Concord Biotech&#8217;s growth prospects and profitability in relation to its peers in the healthcare sector. The company&#8217;s ability to generate returns on equity and capital employed will be critical factors in sustaining investor interest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">87.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.61x to 3,439.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,150.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.64 crore<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) is classified under sector: Healthcare.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Concord Biotech operates within the healthcare sector, which encompasses a wide range of companies with varying market capitalisations and financial metrics. The sector benchmark, consisting of 198 companies, provides a comprehensive overview of the industry&#8217;s performance.<\/p>\n<p>Within this sector, the P\/E ratio ranges from a minimum of 3.61 to a maximum of 3439.3, with a median of 26.44. Concord Biotech&#8217;s valuation will be compared against these benchmarks to assess its market positioning. The sector&#8217;s P\/B ratio ranges from -16.79 to 16.32, with a median of 1.9, highlighting the diversity in valuations.<\/p>\n<p>The healthcare sector&#8217;s median ROE is 11.07%, with an average of 15.18%, while the median ROCE is 13.24%, with an average of 17.64%. These metrics provide a framework for evaluating Concord Biotech&#8217;s financial performance relative to its peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,921.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,815.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,738.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,653.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,476.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">169.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) has a market capitalisation of Rs 13,150.26 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<p>In the healthcare sector, Concord Biotech competes with several peers, including Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd. These companies vary in market capitalisation and financial metrics, providing a diverse landscape for comparison.<\/p>\n<p>Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,921.65 crore and a P\/E of 29.31, while Kwality Pharmaceuticals Ltd. boasts a higher P\/E of 39.89 and a market cap of Rs 2,815.27 crore. Hikal Ltd., with a market cap of Rs 2,738.51 crore, offers a P\/B ratio of 2.23. These comparisons highlight the competitive environment in which Concord Biotech operates.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Concord_Biotech\"><\/span><strong>Why Investors Are Watching Concord Biotech<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Concord Biotech&#8217;s recent price rise has caught the attention of investors and analysts alike. The company&#8217;s performance today, marked by a 5.88% increase in share price, positions it as a notable player in the healthcare sector.<\/p>\n<ul>\n<li>Significant price rise of 5.88% today.<\/li>\n<li>Strong trading volume and market interest.<\/li>\n<li>Operates in a competitive healthcare sector.<\/li>\n<li>Valuation metrics compared to sector benchmarks.<\/li>\n<\/ul>\n<p>Investors will continue to monitor Concord Biotech&#8217;s performance, focusing on its ability to sustain momentum and deliver financial results in line with sector expectations.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Concord_Biotech\"><\/span><strong>About Concord Biotech<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Concord Biotech Ltd. is a prominent player in the healthcare sector, focusing on the development and manufacturing of biopharmaceutical products. The company operates within the pharmaceuticals and drugs industry, offering a range of products that cater to various medical needs.<\/p>\n<p>With a strong emphasis on research and development, Concord Biotech aims to deliver innovative solutions that address critical healthcare challenges. The company&#8217;s commitment to quality and sustainability has positioned it as a trusted partner in the healthcare industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Concord_Biotech_Share_Price_on_Univest\"><\/span><strong>Track Concord Biotech Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\">Concord Biotech Ltd. (CONCORDBIO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors and market enthusiasts can track Concord Biotech Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, and market trends, enabling users to make informed investment decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Concord_Biotech\"><\/span><strong>What is the current share price of Concord Biotech?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Concord Biotech is Rs 1,328, reflecting a 5.88% increase from the previous close of Rs 1,254.2. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Concord_Biotechs_share_price_rise_today\"><\/span><strong>How much did Concord Biotech&#39;s share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s share price rose by 5.88% today, marking a significant gain in the mid cap category. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Concord_Biotechs_PE_ratio_compare_to_the_sector_median\"><\/span><strong>How does Concord Biotech&#39;s P\/E ratio compare to the sector median?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> 44, offering a benchmark for comparison. The relevant peer median P\/E is 26.44x. The peer average P\/E is 87.62x. The stock belongs to the Healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_sector_benchmark_for_ROE_in_healthcare\"><\/span><strong>What is the sector benchmark for ROE in healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The sector benchmark for ROE in healthcare is a median of 11.07% and an average of 15.18%, providing a context for evaluating company performance. The relevant peer median ROE is 11.07%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_are_Concord_Biotechs_main_competitors\"><\/span><strong>Who are Concord Biotech&#39;s main competitors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s main competitors include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd., among others in the healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_track_Concord_Biotechs_share_price\"><\/span><strong>How can I track Concord Biotech&#39;s share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Concord Biotech&#39;s share price on Univest, which provides real-time updates, technical indicators, and market insights. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concord Biotech Ltd. Share Price rises to Rs Rs 1,328. marking a 5.88% rise today. clearing the 5% threshold for Mid Cap stocks. Market cap stands at Rs<\/p>\n","protected":false},"author":29,"featured_media":176703,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-176704","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["176703"],"rank_math_title":["Concord Biotech Share Price Rises 5.88% Today"],"rank_math_description":["Concord Biotech Share Price rises 5.88% today. Explore price action, technicals, fundamentals, and sector analysis for deeper insights."],"rank_math_focus_keyword":["Concord Biotech Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Concord_Biotech_Ltd_CONCORDBIO_Concord_Biotech_Share_Price_Rises_588_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/176704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=176704"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/176704\/revisions"}],"predecessor-version":[{"id":176705,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/176704\/revisions\/176705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/176703"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=176704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=176704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=176704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}